• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Wenqi,LU Xiuhua.Clinical observation of Melilotus Extract Tablets combined with Dujiu for treating ankylosing spondylitis[J].Journal Of Pharmaceutical Research,2016,35(3):182-184[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4035times   Download 3533次 QR Code for this article
Scan with your phone!
草木樨流浸液片联合督灸治疗强直性脊柱炎的临床观察
刘文启1,卢秀花2
Font:Larger+|Default|Smaller-
(1.临沂市人民医院,山东 临沂 276003;2.临沂市沂水中心医院,山东 临沂 276400)
摘要:
目的 观察草木樨流浸液片(MET)联合督灸对强直性脊柱炎(AS)患者的临床疗效及对血清T淋巴细胞亚群的影响,探讨草木樨流浸液片对强直性脊柱炎的药理作用机制。方法 将40例符合标准的HLA-B27阳性强直性脊柱炎患者随机分为两组,试验组给予草木樨流浸液片联合督灸治疗,对照组给予双氯芬酸钠片,分别于治疗前及治疗4周后评估患者病情活动性,采用流式细胞仪检测患者血清T淋巴细胞亚群水平。结果 1治疗前,两组患者血沉、C反应蛋白差异无统计学意义(P>0.05);T淋巴细胞亚群水平差异无统计学意义(P>0.05);2治疗4周后,受试者病情明显改善,试验组有效率高于对照组;草木樨流浸液片联合督灸组胃肠道不良反应发生率(0/20)低于对照组(4/20);T淋巴细胞亚群CD3+、CD4+水平高于对照组(P<0.05)。结论 草木樨流浸液片联合督灸能够纠正强直性脊柱炎患者淋巴细胞亚群亚群紊乱,从而发挥临床疗效。
关键词:  草木樨流浸液片  HLA-B27  强直性脊柱炎  T淋巴细胞亚群
DOI:10.13506/j.cnki.jpr.2016.03.017
基金项目:
Clinical observation of Melilotus Extract Tablets combined with Dujiu for treating ankylosing spondylitis
LIU Wenqi1,LU Xiuhua2
(1.LinYi People's Hospital,Linyi 276003,China;2.YiShui Central Hospital,Linyi 276400,China)
Abstract:
Objective To investigate the effect of Melilotus Extract Tablets (Met) with DuJiu on inflammatory cytokines (TNF-α,IL-2,IL-6) in ankylosing spondylitis with positive HLA-B27, and explore it's mechanism of clinical efficacy.Methods 40 AS patients with positive HLA-B27 were randomly divided into two groups:treatment group received Met,control group received diclofenac.Clinical manifestation and disease activities index were recorded,serum levels of T lymphocyte were determined by Using Flow Cytometry method in the patients of AS.Results There were no significant difference before therapy between the two groups(P>0.05) in CRP and ESR and the T lymphocyte,After 4 weeks treatment,all patients had obviously improvement in CRP and ESR,there were no significant difference between the two groups of the number of adverse drug reactions (ADRs) after 4 weeks treatment , but the gastrointestinal tract ADRs in Met group was lower than the diclofenac group(P<0.05).Comparing the index of inflammatory factors of two groups,the Met group's was better than the diclofenac group's,the improvement of CD3+ and CD4+ between the two groups were significant differernce(P<0.05).Conclusion The clinical efficacy of Melilotus Extract Tablets with DUjiu was significant,the mechanism may relevant with regulating the levels of T lymphocyte.
Key words:  Melilotus Extract Tablets  HLA-B27  Ankylosing spondylitis  T lymphocyte
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.